epiberberine has been researched along with tetradecanoylphorbol acetate in 1 studies
| Studies (epiberberine) | Trials (epiberberine) | Recent Studies (post-2010) (epiberberine) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
|---|---|---|---|---|---|
| 49 | 0 | 37 | 31,050 | 61 | 2,217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, GL; Feng, CT; Ju, WZ; Ma, ST; Miao, CG; Song, Y; Yu, H; Zhang, XL; Zhou, GL | 1 |
1 other study(ies) available for epiberberine and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
In silico target fishing for the potential bioactive components contained in Huanglian Jiedu Tang (HLJDD) and elucidating molecular mechanisms for the treatment of sepsis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Berberine; Dinoprostone; Drugs, Chinese Herbal; Humans; KB Cells; Platelet Membrane Glycoproteins; Protein Transport; Receptors, G-Protein-Coupled; Receptors, Thromboxane A2, Prostaglandin H2; Sepsis; Tetradecanoylphorbol Acetate | 2015 |